Research Studies

Studies Currently Recruiting

 

 Name of Study  

 Study Type  

  Duration 

  ASPREE  
Aspirin in Reducing Events in the Elderly

 Cardiovascular/Memory / Aspirin 

 5 years 

ADNI 2
Alzheimer’s Disease Neuroimaging Initiative 2

Memory

4 1/2 years

Ongoing Studies

 

 

ACCORDION
Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-Up Study

ACCORDION MIND 
Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-Up Study – Memory in Diabetes Follow-Up Study

  ASPREE HUB
Aspirin in Reducing Events in the Elderly

 LIFE Cognition 
Lifestyle Interventions and Independence for Elders Cognitive Sub Study

Look AHEAD Ancillary Study 
Ancillary Study Intentional Weight Reduction and Physical and Cognitive Function

SPRINT
Systolic Blood Pressure Intervention Trial

SPRINT MIND
The SPRINT Memory and Cognitive IN Decreased hypertension

Completed Studies

 

ACCORD
Action to Control Cardiovascular Risk in Diabetes

ACCORD MIND
Action to Control Cardiovascular Risk in Diabetes – Memory in Diabetes

 ADNI
Alzheimer's Disease Neuroimaging Initiative

AIM HIGH 
Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes 

BMS
BMSA Multicenter, Randomized Double-Blind Placebo-Controlled Study of the safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients with Prodromal Alzheimer's Disease

 DHA
A Randomized Double-Blind Placebo-Controlled Trial of the Effects of Docosahexaenoic Acid (DHA) in Slowing the Progression of Alzheimer's Disease

DHS MIND
Genetics of Cerebrovascular Disease and Cognitive Impairment in the Diabetes Heart Study

 GEM
Ginkgo Evaluation of Memory

HBA
Multi-Center Trial to Evaluate Home-Based Assessment Methods for Alzheimer Disease Prevention Research in People Over 75 Years Old

ICARA
A Phase III, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) In Patients With Mild to Moderate Alzheimer's Disease Who Are Apolipoprotein E4 Non-Carriers (301) or Carriers (302)

 IDENTITY
Effect of γ-Secretase Inhibition on the Progression of Alzheimer’s Disease: LY450139 versus Placebo

MY BUDDY
Community-based, buddy-supported exercise in patients with MCI

OPTIMA
Optimizing Body Composition in Older Adults

A Randomized Controlled Trial to Assess the Efficacy of a Medical Food in Patients with Mild to Moderate Alzheimer’s Disease using Alzheimer’s Disease Medication


Quick Reference

Gerontology and Geriatric Medicine

Geriatric Administration
336-713-8570
Geriatric Clinic
336-713-8250
Geriatric Research
336-713-8539
Elder Law Clinic
336-713-8630

Find A Doctor Ways to Give
Last Updated: 08-28-2014
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.